Three months of rifapentine and isoniazid for latent tuberculosis infection.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE, TB Trials Consortium PREVENT TB Study Team

Open source

DOI: 10.1056/nejmoa1104875
Published: 2011 Dec 8
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1104875,
  title = {Three months of rifapentine and isoniazid for latent tuberculosis infection.},
  author = {Sterling TR and Villarino ME and Borisov AS and Shang N and Gordin F and Bliven-Sizemore E and Hackman J and Hamilton CD and Menzies D and Kerrigan A and Weis SE and Weiner M and Wing D and Conde MB and Bozeman L and Horsburgh CR Jr and Chaisson RE and TB Trials Consortium PREVENT TB Study Team},
  year = {2011},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1104875},
  url = {https://doi.org/10.1056/nejmoa1104875}
}

RIS

TY  - JOUR
TI  - Three months of rifapentine and isoniazid for latent tuberculosis infection.
AU  - Sterling TR
AU  - Villarino ME
AU  - Borisov AS
AU  - Shang N
AU  - Gordin F
AU  - Bliven-Sizemore E
AU  - Hackman J
AU  - Hamilton CD
AU  - Menzies D
AU  - Kerrigan A
AU  - Weis SE
AU  - Weiner M
AU  - Wing D
AU  - Conde MB
AU  - Bozeman L
AU  - Horsburgh CR Jr
AU  - Chaisson RE
AU  - TB Trials Consortium PREVENT TB Study Team
PY  - 2011
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1104875
UR  - https://doi.org/10.1056/nejmoa1104875
ER  -

APA

TR, S., ME, V., AS, B., N, S., F, G., E, B., J, H., CD, H., D, M., A, K., SE, W., M, W., D, W., MB, C., L, B., Jr, H. C., RE, C., & Team, T. T. C. P. T. S. (2011). Three months of rifapentine and isoniazid for latent tuberculosis infection.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1104875

Source records

pubmed · retrieved 2026-09-26T16:13:34.339Z